This could help clinicians to provide an accurate prognosis, but also target novel therapies that might attenuate or prevent long-term sequelae of enteric infection,” explains Marshall.

Recently, there has been strong interest in the therapeutic potential of probiotics for irritable bowel ... infection and the associated immune activation in the development of post-infectious ...

Vélez wrote that one possible insight is post-infectious irritable bowel syndrome, which is when the network of nerves that connects the gut and the brain is disrupted by something such as the ...

may help alleviate persistent digestive symptoms and improve quality of life for patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), alongside standard drug treatments.

IBD shouldn’t be confused with irritable bowel syndrome (IBS). While some symptoms may be similar at times, the source and course of the conditions differ quite significantly. Crohn’s isn’t ...

A study found that patients with COVID-19 may have a higher risk of developing new gastrointestinal (GI) disorders compared with matched controls, highlighting the need for further research on ...

There was improvement in the Irritable Bowel Syndrome Impact Scale score ... established efficacy in treating Clostridium difficile infection,” the authors write. Several authors disclosed ...

Glucose hydrogen breath test with estimation of methane may be used instead. Post-infective malabsorption syndrome should be excluded by appropriate investigations before a diagnosis of PI-IBS is ...